Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Radixin (RDX) (Middle Region) Peptide

RDX Reactivity: Human Host: Synthetic BP, WB
Catalog No. ABIN982821

Quick Overview for Radixin (RDX) (Middle Region) Peptide (ABIN982821)

Target

Radixin (RDX)

Origin

Human

Source

  • 5
Synthetic

Application

Blocking Peptide (BP), Western Blotting (WB)
  • Protein Region

    Middle Region

    Characteristics

    This is a synthetic peptide designed for use in combination with anti-RDX antibody (Catalog #: ARP56519_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.

    Purification

    Purified
  • Application Notes

    Each Investigator should determine their own optimal working dilution for specific applications.

    Restrictions

    For Research Use only
  • Format

    Lyophilized

    Reconstitution

    Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.

    Concentration

    1 mg/mL

    Buffer

    Final peptide concentration is 1 mg/mL in PBS.

    Handling Advice

    Avoid repeated freeze-thaw cycles.

    Storage

    -20 °C

    Storage Comment

    For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
  • Target

    Radixin (RDX)

    Background

    Radixin is a cytoskeletal protein that may be important in linking actin to the plasma membrane. It is highly similar in sequence to both ezrin and moesin. The radixin gene has been localized by fluorescence in situ hybridization to 11q23. A truncated ver

    Alias Symbols: DFNB24

    Protein Interaction Partner: SLC9A3R1,TSC1,ABCC2,ARHGDIA,CPNE1,CPNE2,CPNE4,EZR,GNA13,ICAM2,ITGB2,L1CAM,ROCK1,SLC9A3R1,SLC9A3R2,TSC1,ARHGDIA,DRD3,GNA13,ICAM2,PHLPP2

    Protein Size: 583

    Molecular Weight

    68 kDa

    Gene ID

    5962

    NCBI Accession

    NM_002906, NP_002897

    UniProt

    P35241
You are here:
Chat with us!